Why the study?
Can an aldosterone synthase (CYP11B2)–specific 18F-labeled radioligand be used for PET imaging in primary aldosteronism?
Can an aldosterone synthase (CYP11B2)–specific 18F-labeled radioligand be used for PET imaging in primary aldosteronism?
A novel PET imaging method using an 18F-labeled radioligand specific to aldosterone synthase was developed for evaluating primary aldosteronism.
Answers are grounded in this paper and cite their sources.
May enable noninvasive evaluation in primary aldosteronism; leaves open diagnostic accuracy and clinical utility pending validation.
In this pilot study, a method of imaging in primary aldosteronism was developed with the use of an aldosterone synthase (CYP11B2)–specific 18F-labeled radioligand for use with positron-emission tomography.
No takes yet. Share an insight, caveat, or question.
Årstad et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: